Most Awaited Q3 Sale is back. Upto 30% discount on every report.

Regenerative Medicine Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 August 25
SKU : BT775
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Regenerative Medicine Market is segmented By Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineering, StemCell, Others), By Product(Autologous Cell-Base Products, Allogeneic Cell-Based Products, Acellular Products), By Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Neurology, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030


Regenerative Medicine Market Size

Regenerative Medicine Market value is US$ 12.1 Billion in 2022US$ 62.3 Billion in 2030 and is expected to grow at a CAGR of 23.7%  during the forecast period (2023-2030).

Regenerative medicine is an emerging field that aims to repair and replace damaged organs and tissues. It is the potential for the treatment of chronic diseases and disorders, such as Alzheimer’s disease, diabetes, and others. Regenerative medicine is an interdisciplinary field that applies engineering and life science principles to encourage regeneration. It can restore diseased and injured tissues and whole organs.

Regenerative Medicine Market Scope



Market CAGR


Segments Covered

By TherapyType, By Product, By Application, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America


For More Insights about the Market Request Free Sample


Regenerative Medicine Market Trends

The global regenerative medicine market growth is driven by the rising prevalence of chronic diseases and genetic disorders. Other factors are the increase in global healthcare expenditure, rapid growth in the aging population, and an increase in government & private funding to support the development of regenerative medicine.

The growing prevalence of chronic diseases, genetic disorders, and cancer will drive the market growth    

The incidence and prevalence of chronic diseases such as CVD, cancer, diabetes, ulcers, and genetic disorders such as cystic fibrosis have increased significantly across the globe, over the last few decades. The increased incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, can be a result of diabetes and obesity, which will require treatments and incur exorbitant medical expenses.

The market is found experiencing the major technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth. There are also various recent advancements in regenerative medicine, including the regenerated tracheas for transplant, 3D bioprinting, stem cell treatments for vision loss, and stem cell treatments for heart repair.

The current market is also witnessing extensive R&D activities. Apart from the R&D activities being conducted by private players, there is significant involvement of academic institutions in conducting various research. Therefore, in the future, several new biotech and med-tech companies are expected to come up, as the result of the current R&D endeavors across the world.

Growing research and development by the organizations to discover innovative medicine will significantly influence the regenerative medicine market expansion. The industry has observed significant growth in research funding over the past few years. For instance, as per the Alliance for Regenerative Medicine, overall financing increased from USD 9.8 billion in 2019 to USD 19.9 billion in 2020. Rising funding has further allowed organizations to strengthen their product development capabilities, thereby augmenting the market growth in the forecast period.

The high cost of cell and gene therapies will hamper the growth of the market

Patients suffering from terminal illnesses and serious disorders require cell and gene therapies which represent a significant scientific and medical advancement. These therapies are helping to transform how diseases are treated and potentially cured. Furthermore, such therapies will eventually enable doctors and medical professionals to infuse genes/cells via injectable means in order to avoid a series of drugs and multiple surgeries in patients. However, despite the fact of these therapies are lifesavers and more effective compared to the traditional treatments, the response in terms of demand for these therapies is less compared to the anticipation. This can be attributed to the high costs of these therapies and the difficulty in obtaining reimbursements and coverage for these therapies.   

COVID-19 Impact Analysis on Regenerative Medicine Market

The COVID-19 outbreak will impact the regenerative medicine market in the initial phase of the forecast period. Due to nationwide lockdowns, denied wound care services, canceled or postponed elective surgeries, and increasing skin injuries in COVID-19 medical care providers, the regenerative medicine market is expected to register a certain decline during the forecast period. However, during the latter half of the forecast period, the demand for regenerative medicine products is expected to rise drastically. Singapore-based Duke-NUS medical school’s emerging infectious diseases research program demonstrated the utility of these immunotherapies in treating patients with COVID-19 infection. The presence of several programs and continuous investments by government and private agencies to support R&D also accelerate the industry's progress.

Regenerative Medicine Market Segment Analysis

The dermatology segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

Dermatology is estimated to have the largest share of revenue generation, and this high contribution is attributed to the presence of easy grafting techniques for dermatological wounds and diseases. Skin, being an organ with great cell replication characteristics, provides various types of stem cells from its different layers. Therefore, there is a broad range of products present, from patches to cure small injuries to matrix and grafts for chronic wounds and burns. Thus, the segment is expected to continue to dominate the market through the forecast period.

The increasing number of accidents and bone defects is also expected to drive the regenerative medicine market. There are also several research studies that are being conducted on tissue engineering for the development of bone graft substitutes, with the help of regenerative medicine. So, with the new advances in bone grafts, the market is expected to grow over the forecast period.

Global Regenerative Medicine Market Geographical Share

North America region holds the largest market share of the global regenerative medicine market

North America is estimated to have the largest share, in terms of revenue, owing to the presence of major players and rapid advances in technology, along with high investments in stem cell and oncology research. There is also an increasing prevalence of diseases, such as cancer and diabetes, which can now be cured by various stem cell therapies. Additionally, the awareness regarding the available stem cell procedures and therapies among people is rising, which in turn, is increasing the demand for the overall market. Moreover, its broad base of the patient population and the presence of significant medical companies along with the extensive research activities undertaken by a majority of prominent local players contribute to the growth of North America’s share in the regenerative medicine market.

The high investment and funding to support the development of regenerative medicine. Availability of funds as well as several initiatives by the government & private organizations contributes to the highest revenue flow from the U.S. For instance, the “2020: A New Vision” initiative of the U.S. Department of Health and Human Services recognizes regenerative medicine at the forefront of healthcare. These factors are driving the growth of the market in the region.

Regenerative Medicine Companies and Competitive Landscape

The regenerative medicine market is a moderately competitive presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include Allergan Plc, Osiris Therapeutics (Smith & Nephew), Integra Lifesciences, Cook Biotech Incorporated, and Organogenesis Inc., Baxter, Medtronic Plc, Thermo Fisher Scientific, Sigma-Aldrich Co., Becton Dickinson and Company among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the regenerative medicine market globally. For instance, in January 2018, RepliCel Life Sciences Inc. formed a partnership with the private firm, China-based Yofoto Health Industry Co. Ltd for regenerative medicine. This partnership builds on RepliCel’s existing alliance in Japan with Shiseido. Yofoto intents to expand into more scientifically sophisticated markets, including gene-based blood testing and regenerative medicine, and in establishing its network of wellness clinics in partnered geographies.

Osiris Therapeutics


The company's therapeutic areas focus on innovation in regenerative medicine, including bioengineering, stem cell research, and viable tissue-based products, intended to improve the health and lives of patients and lower overall healthcare costs.     

Product Portfolio:

PuraPly Antimicrobial (PuraPly AM):  PuraPly AM Wound Matrix is cleared Class II medical device that is indicated for the management of a variety of acute and chronic wounds, including partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, trauma wounds, draining wounds, and first– and second–degree burns.

The global regenerative medicine market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 190  pages.


Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
Request new version
What is the market size of Regenerative Medicine Market?
The Regenerative Medicine Market value is US$ 12.1 Billion in 2022, and is expected to grow US$ 62.3 Billion in 2030.
Which was the leading segment in the regenerative medicine market in terms of applications in 2023?
Oncology segment was leading the regenerative medicine market in terms of applications in 2023.
What is the Projected CAGR value of the Regenerative Medicine Market ?
Regenerative Medicine Market is expected to grow at a CAGR of 23.7% during the forecast period 2023-2030.
Who are the key Companies in Regenerative Medicine Market ?
Major players are Osiris Therapeutics (Smith & Nephew), Integra Lifesciences, Cook Biotech Incorporated, Organogenesis Inc, Baxter, Medtronic Plc, Thermo Fisher Scientific, Sigma-Aldrich Co and Becton Dickinson and Company.
Related Reports

Stem Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 01
Starting from



Respiratory Syncytial Virus (RSV) Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 21
Starting from



Next Generation Antibody Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 November 01
Starting from



Gene Expression Analysis Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 20
Starting from



Difficult-to-Express Proteins Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 22
Starting from



Synthetic Biology Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 July 27
Starting from